Skip to main content
Clinical Trials/NCT07561255
NCT07561255
Recruiting
Not Applicable

Real-world Quality Management Study With Axia to Evaluate the Measures of the DigiG (RAEMD Study)

Wuerzburg University Hospital7 sites in 1 country200 target enrollmentStarted: April 10, 2026Last updated:

Overview

Phase
Not Applicable
Status
Recruiting
Enrollment
200
Locations
7
Primary Endpoint
Percentage of participants with successful Axia app activation within 12 weeks, assessed by successful redemption of the activation code

Overview

Brief Summary

This prospective, multicenter, controlled real-world quality management study explores the acceptance and utility of two measures discussed in the context of the German Digital Act (DigiG) for the digital health application (DiGA) Axia: a 14-day trial period and an application-related outcome measurement (AbEM). Patients with axial spondyloarthritis in Axia's indication area who are eligible for prescription in routine care will receive one of two onboarding brochure versions in a 1:1 allocation: either the standard access procedure or immediate 14-day trial access until the health insurance activation code arrives. The manufacturer will analyze aggregated anonymized data to compare voucher redemption and app activation frequencies between groups and to assess acceptance and return rates of a voluntary five-item AbEM questionnaire at weeks 6 and 12. Secondary analyses will descriptively evaluate AbEM results and anonymized usage data.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
Single (Care Provider)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Willingness to use Axia.
  • Axia indication area.
  • Willingness to activate via onboarding brochure.

Exclusion Criteria

  • Absence of the inclusion criteria

Arms & Interventions

Standard procedure

Active Comparator

Intervention: Standard procedure (Other)

Immediate app-use by a test phase

Experimental

Intervention: Test-phase with immediate access (Device)

Outcomes

Primary Outcomes

Percentage of participants with successful Axia app activation within 12 weeks, assessed by successful redemption of the activation code

Time Frame: 12 weeks

Successful app activation is defined as successful redemption of the activation code by the participant. The outcome measure is the percentage of participants with successful app activation from baseline through week 12.

Secondary Outcomes

  • Percentage of participants with a voluntarily completed application-related success measurement questionnaire (AbEM)(6 and 12 weeks)
  • Mean AbEM questionnaire item scores among participants with a completed AbEM questionnaire(6 and 12 weeks)
  • Exploratory analysis of anonymized usage data.(12 weeks)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Patrick-Pascal Strunz

PD. Dr. med.

Wuerzburg University Hospital

Study Sites (7)

Loading locations...

Similar Trials